News Focus
News Focus
Replies to #83511 on Biotech Values
icon url

rkrw

09/13/09 9:23 PM

#83519 RE: DewDiligence #83511

You're ascribing almost $9B in potential market valuation for m-lovenox, a generic drug. This just doesn't compute for me. This is over 50% of all of Allergan, 2/3rd of Biogen, 60% of all of Genzyme.